コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ght at a flux of less than 1 sun (1 kilowatt per square meter).
2 sed cardiac index (<or=2.2 liters per minute per square meter).
3 ter) or every 2 weeks (with a dose of 500 mg per square meter).
4 crystal lattice distortion (0.02 megajoules per square meter).
5 rent sheets (tens to hundreds of nanoamperes per square meter).
6 0.0001) increase in risk with each kilogram per square meter.
7 ross the ocean surface of 0.4 +/- 0.05 watts per square meter.
8 positivity and doxorubicin doses above 60 mg per square meter.
9 diac index was 1.60+/-0.35 liters per minute per square meter.
10 ndogenic heat fluxes locally reaching 1 watt per square meter.
11 chanical power with a potential for >6 watts per square meter.
12 ordinarily high toughness of ~100 kilojoules per square meter.
13 nditions with a solar intensity of 850 watts per square meter.
14 idopsis leaves at 10-15 nmol AtRAF1 monomers per square meter.
15 ne-of-sight column densities of about 10(20) per square meter.
16 has a dilution effect on energy consumption per square meter.
17 lerated dose of interleukin-2 was 1x10(6) IU per square meter.
18 1% probability of being lower than 2.6 watt per square meters.
19 ice flow, packed at densities of ten animals per square meter?
20 S from 1983 to 2001 at a rate of 0.16 watts per square meter (0.10%) per year; this change is a comb
21 effect of body mass index (BMI, in kilograms per square meter) 5 years before diagnosis on risk of de
22 2100, we project median forcings of 5.1 watt per square meters (5th to 95th percentiles of 3.3 to 7.1
24 ecreased significantly from baseline (-7.7 g per square meter; 95% confidence interval [CI], -15.4 to
25 esults of a high-resolution (>/=nine returns per square meter) airborne light detection and ranging (
27 up (mean improvement over baseline, -14.1 ml per square meter and -14.6 ml per square meter, respecti
28 acement (mean changes from baseline, -9.0 ml per square meter and -6.5 ml per square meter, respectiv
29 chieved a record power density of 85.1 watts per square meter and an osmotic potential of 181.5 milli
30 ce response with a threshold of 10(-9) moles per square meter and is not reversible by far red light.
31 o both surface energy (up to 0.29 megajoules per square meter) and energy associated with crystal lat
32 c coefficients (e(31,f) = -27 +/- 3 coulombs per square meter) and figures of merit for piezoelectric
33 ted with body mass index (BMI) (in kilograms per square meter) and positively correlated with scores
34 The correlation between dose (millicuries per square meter) and thrombocytopenia was made stronger
35 c flow (6.2 +/- 2.4 versus 9.4 +/- 3.4 L/min per square meter), and peak arch velocity (1.9 +/- 0.7 v
36 status, body mass index (BMI) (in kilograms per square meter), and resource utilization band (RUB) (
37 ughly 0.5% probability of exceeding 8.5 watt per square meters, and a 1% probability of being lower t
40 weeks every six weeks; fluorouracil (425 mg per square meter as an intravenous bolus) and leucovorin
41 an intravenous bolus) and leucovorin (20 mg per square meter as an intravenous bolus) daily for five
42 an intravenous bolus), and leucovorin (20 mg per square meter as an intravenous bolus) weekly for fou
43 ce area intravenously), fluorouracil (500 mg per square meter as an intravenous bolus), and leucovori
44 ter of body-surface area, increased to 1.0 g per square meter) as induction therapy for active lupus
45 +/- 65.8 and 736.6 +/- 57.8 grams of carbon per square meter at +9 degrees C under aCO(2) and eCO(2)
46 Given the amount of solar energy available per square meter at the Earth's surface, however, it is
48 er an 80-year fire cycle (-2.3 +/- 2.2 Watts per square meter) because multidecadal increases in surf
49 t Missions and is found to average 1.8 watts per square meter between 30 degrees S and 30 degrees N.
50 with seven daily doses of cytarabine (100 mg per square meter) by continuous intravenous infusion.
52 of body-surface area) or a high dose (90 mg per square meter), combined with seven daily doses of cy
53 eat flux (approximately 85 +/- 25 milliwatts per square meter), comparable to the average at Earth's
54 x at the top of the atmosphere was -15 watts per square meter, comparable to the aerosol indirect eff
55 sol climate forcings of as much as -0.8 watt per square meter cooling and +0.3 watt per square meter
56 estimated to be no more than about -0.3 watt per square meter (cooling), compared with +2.45 watts pe
58 of body-surface area and 750 mg of etoposide per square meter, each for 3 consecutive days, and each
62 into human skin is around 79.58 milliamperes per square meter, far below the safety threshold for med
63 oses) and 105 to receive dexrazoxane (300 mg per square meter) followed immediately by doxorubicin.
65 rgy per unit fault surface is ~13 megajoules per square meter for heat, which is predominant with res
68 -surface area) plus cyclophosphamide (600 mg per square meter) for four cycles, followed by four cycl
70 T concentrations [grams of active ingredient per square meter (g ai/m(2))] were determined using HPLC
72 ys 1 and 29, followed by 4 g of fluorouracil per square meter given as a 96-hour infusion on days 1 a
73 r 5 days every 28 days), chlorambucil (40 mg per square meter, given orally every 28 days), or fludar
74 lds an interfacial toughness of 6 kilojoules per square meter (>1.8x literature benchmarks; 1.4 to 3.
75 ts in the group assigned to 16 mg of TNFR:Fc per square meter had improvement of 20 percent or more i
76 ntation with a higher melphalan dose (200 mg per square meter) had induced only a partial, transient
77 suggests that the peak of energy consumption per square meter in China's urban residential buildings
78 tantaneous forcing of climate from -28 watts per square meter in cloud-free conditions to +8 watts pe
79 up to 97% of UV radiation from 5 to 90 watts per square meter in less than 16.9 seconds, demonstratin
82 a in the CABG-alone group and 49.6+/-31.5 ml per square meter in the combined-procedure group (mean c
83 a in the CABG-alone group and 43.2+/-20.6 ml per square meter in the combined-procedure group (mean i
84 area in the repair group and 60.7+/-31.5 ml per square meter in the replacement group (mean change f
88 cted sunlight decreased by less than 2 watts per square meter, in the tropics over the period 1985-20
89 ntury (the probability of exceeding 8.5 watt per square meters increases to about 7% by 2150), and as
90 ntravenously on day 1) and etoposide (120 mg per square meter intravenously on days 1, 2, and 3) admi
91 very four weeks; or irinotecan alone (125 mg per square meter intravenously) weekly for four weeks ev
93 l endogenic heat flux of 46 +/- 4 milliwatts per square meter is required to match the observed radia
94 ean relationship of the numbers of parasites per square meter is very well described by TL but is not
95 d less UV light exposure (median, 555 Joules per square meter [J/m(2); interquartile range, 322-1210
96 duals and were associated with 1.8 kilograms per square meter lower BMI and 54% lower odds of obesity
97 t Earth is now absorbing 0.85 +/- 0.15 watts per square meter more energy from the Sun than it is emi
98 local surface heat flux changes (+/-4 watts per square meter) much larger than the basinwide average
99 pproximately 240 and 1300 mug total fluorine per square meter (mug F/m(2)) were released from the PA
100 vity, core heat flux is 80 to 160 milliwatts per square meter (mW m(-2)) into the coldest D'' region
101 nited States, the GWP in kg CO(2) equivalent per square meter of altered surface ranges from 0.8 to 1
102 reated patients with 3 x 10(6) CAR-NKT cells per square meter of body surface area after lymphodeplet
103 trexate use and received 24 mg of adalimumab per square meter of body-surface area (maximum dose, 40
104 umulative procarbazine dose of 4.3 g or more per square meter of body-surface area (which has been as
105 imab maintenance therapy at a dose of 375 mg per square meter of body-surface area administered every
106 riority trial, we compared rituximab (375 mg per square meter of body-surface area administered once
107 otherapy consisting of 700 mg of carboplatin per square meter of body-surface area and 750 mg of etop
108 weeks) or dacarbazine (at a dose of 1000 mg per square meter of body-surface area every 3 weeks and
109 ither ADT plus docetaxel (at a dose of 75 mg per square meter of body-surface area every 3 weeks for
110 ministered intravenously at a dose of 175 mg per square meter of body-surface area every 3 weeks, plu
111 ry 2 weeks, or docetaxel, at a dose of 75 mg per square meter of body-surface area every 3 weeks.
112 very 2 weeks or docetaxel at a dose of 75 mg per square meter of body-surface area every 3 weeks.
113 with ALL to receive doxorubicin alone (30 mg per square meter of body-surface area every three weeks
114 d by one course of high-dose cytarabine (3 g per square meter of body-surface area for six doses).
115 , the mean (+/-SD) LVESVI was 41.2+/-20.0 ml per square meter of body-surface area in the CABG-alone
116 among surviving patients was 46.1+/-22.4 ml per square meter of body-surface area in the CABG-alone
117 among surviving patients was 54.6+/-25.0 ml per square meter of body-surface area in the repair grou
118 ) to receive cabazitaxel (at a dose of 25 mg per square meter of body-surface area intravenously ever
119 orally twice daily) or dacarbazine (1000 mg per square meter of body-surface area intravenously ever
120 treatment plus concurrent cisplatin (100 mg per square meter of body-surface area intravenously on d
121 ither four 28-day cycles of cisplatin (60 mg per square meter of body-surface area intravenously on d
122 domly assigned to receive irinotecan (125 mg per square meter of body-surface area intravenously), fl
123 l selumetinib twice daily at a dose of 25 mg per square meter of body-surface area on a continuous do
124 istered twice daily at a dose of 20 to 30 mg per square meter of body-surface area on a continuous do
125 vant therapy consisting of docetaxel (100 mg per square meter of body-surface area on day 1), docetax
126 aily on days 1 through 5, 60 mg of docetaxel per square meter of body-surface area on day 2, and 60 m
127 ously plus capecitabine at a dose of 2000 mg per square meter of body-surface area on days 1 through
128 cristine with bortezomib at a dose of 1.3 mg per square meter of body-surface area on days 1, 4, 8, a
129 gned patients to receive 90 mg of paclitaxel per square meter of body-surface area on days 1, 8, and
130 us either a combination of etoposide (100 mg per square meter of body-surface area on days 2 to 4), d
131 lone or in combination with cisplatin (40 mg per square meter of body-surface area once a week for up
132 and a cardiac index of 2.7 liters per minute per square meter of body-surface area or less were rando
133 to receive 135 mg of intravenous paclitaxel per square meter of body-surface area over a 24-hour per
134 rses of intravenous cyclophosphamide (600 mg per square meter of body-surface area per course) plus e
135 then adjusted to a target of 8.0 to 10.0 mg per square meter of body-surface area per day (hydrocort
136 ve days of treatment with 12 mg of cisplatin per square meter of body-surface area per day and 600 mg
137 citabine was administered at a dose of 20 mg per square meter of body-surface area per day for 10 con
138 glucocorticoid dose at baseline was 17.6 mg per square meter of body-surface area per day of hydroco
139 ted with higher doses of bexarotene (>300 mg per square meter of body-surface area per day) and in th
140 he regimen consisted of fluorouracil (500 mg per square meter of body-surface area per day) during fr
141 reatment consisted of 425 mg of fluorouracil per square meter of body-surface area per day, plus 20 m
142 postinduction course of blinatumomab (15 mug per square meter of body-surface area per day; 28-day co
143 d to immediate acyclovir suppression (300 mg per square meter of body-surface area per dose orally, t
144 y, noninferiority trial of rituximab (375 mg per square meter of body-surface area per week for 4 wee
145 en plus either rituximab at a dose of 375 mg per square meter of body-surface area per week for 4 wee
146 ee chemotherapy regimens: 40 mg of cisplatin per square meter of body-surface area per week for six w
147 study compared melphalan at a dose of 200 mg per square meter of body-surface area plus autologous st
149 ean (+/-SD) 2-year LVESVI was 52.6+/-27.7 ml per square meter of body-surface area with mitral-valve
150 yeloablative chemotherapy (melphalan, 140 mg per square meter of body-surface area) and autologous st
151 mly assigned to receive gemcitabine (1000 mg per square meter of body-surface area) and carboplatin (
152 tive cycles of intravenous epirubicin (50 mg per square meter of body-surface area) and cisplatin (60
153 ltiple myeloma to receive bortezomib (1.3 mg per square meter of body-surface area) and dexamethasone
154 erformance status) to nab-paclitaxel (125 mg per square meter of body-surface area) followed by gemci
155 milliliter per minute) and paclitaxel (50 mg per square meter of body-surface area) for 5 weeks and c
156 rleukin-2 (0.3x10(6), 1x10(6), or 3x10(6) IU per square meter of body-surface area) for 8 weeks.
157 r an intravenous bolus of bortezomib (1.3 mg per square meter of body-surface area) on days 1, 4, 8,
158 atients with two cycles of rituximab (375 mg per square meter of body-surface area) once weekly for 3
159 norubicin at either the standard dose (45 mg per square meter of body-surface area) or a high dose (9
160 erapy who were receiving cisplatin (>/=70 mg per square meter of body-surface area) or cyclophosphami
161 chemotherapy with either pemetrexed (500 mg per square meter of body-surface area) or docetaxel (75
162 ce daily or intravenous dacarbazine (1000 mg per square meter of body-surface area) or paclitaxel (17
163 f intravenous cyclophosphamide (0.5 to 1.0 g per square meter of body-surface area) plus corticostero
164 ned to receive doxorubicin (60, 75, or 90 mg per square meter of body-surface area) plus cyclophospha
165 of three doses of TNFR:Fc (0.25, 2, or 16 mg per square meter of body-surface area) twice weekly for
166 illiliter per minute) and paclitaxel (175 mg per square meter of body-surface area), every 3 weeks (s
169 concurrent and sequential rituximab (375 mg per square meter of body-surface area, administered for
170 the following treatments: fludarabine (25 mg per square meter of body-surface area, administered intr
171 (211 patients) at an initial dose of 400 mg per square meter of body-surface area, followed by 250 m
172 week (with an initial loading dose of 400 mg per square meter of body-surface area, followed by a dos
173 monthly intravenous cyclophosphamide (0.5 g per square meter of body-surface area, increased to 1.0
174 f intravenous paclitaxel at a dose of 175 mg per square meter of body-surface area, plus carboplatin
175 py consisted of cisplatin at a dose of 50 mg per square meter of body-surface area, plus paclitaxel a
176 x10(11), 2.2x10(11), or 4.4x10(11) platelets per square meter of body-surface area, respectively), wh
177 gave everolimus orally, at a dose of 3.0 mg per square meter of body-surface area, to achieve a trou
178 rcing during the first year (34 +/- 31 Watts per square meter of burned area), but to decrease radiat
179 ower density using acetate reached 5.6 watts per square meter of cathode surface area, which was five
180 boundary fault corresponds to 27 megajoules per square meter of dissipated energy during the earthqu
181 Body weight, body mass index (kilograms per square meter of height), and waist circumference wer
182 sulting in the generation of >400 milliwatts per square meter of mechanical power with a potential fo
183 elds at our site emits 18 to 31 g of methane per square-meter of field area per season, potentially d
184 ge adhesion energy (approximately 2.3 joules per square meter) of Ag nanoparticles to reduced CeO2(11
185 s before docetaxel, or 12 mg of mitoxantrone per square meter on day 1 plus 5 mg of prednisone twice
186 ody-surface area on day 1), docetaxel (75 mg per square meter on day 1) plus capecitabine (825 mg per
187 a day on days 1 to 14), or docetaxel (75 mg per square meter on day 1) plus gemcitabine (1000 mg per
188 ace area on days 2 to 4), doxorubicin (40 mg per square meter on day 1), and cisplatin (40 mg per squ
190 wed by either 75 mg of intravenous cisplatin per square meter on day 2 (intravenous-therapy group) or
191 roup) or 100 mg of intraperitoneal cisplatin per square meter on day 2 and 60 mg of intraperitoneal p
192 ay 2 and 60 mg of intraperitoneal paclitaxel per square meter on day 8 (intraperitoneal-therapy group
193 for six weeks (group 1); 50 mg of cisplatin per square meter on days 1 and 29, followed by 4 g of fl
194 re meter on day 1) plus gemcitabine (1000 mg per square meter on days 1 and 8) for four cycles, with
195 apy (capecitabine alone at a dose of 2500 mg per square meter on days 1 through 14 of a 21-day cycle)
196 uare meter or topotecan at a dose of 0.75 mg per square meter on days 1 to 3, plus paclitaxel at a do
197 square meter on day 1), and cisplatin (40 mg per square meter on days 3 and 4) (EDP) every 4 weeks or
198 r of body-surface area) and cisplatin (60 mg per square meter) on day 1, and a continuous intravenous
200 rface area) followed by gemcitabine (1000 mg per square meter) on days 1, 8, and 15 every 4 weeks or
201 e meter in cloud-free conditions to +8 watts per square meter once the reduction of cloud cover is ac
202 , plus paclitaxel at a dose of 135 or 175 mg per square meter or topotecan at a dose of 0.75 mg per s
203 y-surface area, followed by a dose of 250 mg per square meter) or every 2 weeks (with a dose of 500 m
204 lus either intraperitoneal cisplatin (100 mg per square meter) or intravenous cisplatin (100 mg per s
208 d increased to 2.22+/-0.44 liters per minute per square meter (P<0.001 for the comparison with base l
209 ed further, to 2.52+/-0.55 liters per minute per square meter (P<0.001 for the comparison with base l
210 both greenhouse gases in units of milliwatts per square meter per country or microwatts per square me
212 erived CO(2) flux was 148 +/- 226 millimoles per square meter per day (mmol m(-2) day(-1)), resulting
213 face area per day and 600 mg of fluorouracil per square meter per day during weeks 1 and 6 of irradia
214 orally every 28 days), or fludarabine (20 mg per square meter per day for 5 days every 28 days) plus
215 nd the ratio of day/night FCO(2) (millimoles per square meter per day) decreased from the dry season
217 two five-day cycles of fluorouracil (425 mg per square meter per day) plus leucovorin (20 mg per squ
218 square meter per day) plus leucovorin (20 mg per square meter per day) were given one month apart.
219 ne, the mean glucocorticoid dose was 16.4 mg per square meter per day, and the mean androstenedione l
220 rface area per day, plus 20 mg of leucovorin per square meter per day, for five days, followed by 450
221 ate and grain yield reached 138 and 60 grams per square meter per day, respectively; both continued t
223 es per square meter per second; 22-150 moles per square meter per day; 16-20 hour photoperiod) in a n
224 atmospheric heating locally by about 3 watts per square meter per decade (similar in magnitude to the
226 meter, an average power output of 4.46 watts per square meter per hertz, and an energy conversion eff
227 esponding to 0.31, 0.30, 0.25, 0, and 0 mole per square meter per hour in 120 minutes, respectively.
229 and the highest DMHg evasion (~9.4 picomoles per square meter per hour) found in upwelling waters nea
230 a magnitude of 0.54 +/- 0.74 (2sigma) watts per square meter per kelvin, meaning that it is likely p
233 the following permeances, measured in moles per square meter per Pascal per second: nitrogen, 1.8 x
234 s per square meter per country or microwatts per square meter per person, a metric we term internatio
235 hours dim incandescent (INC) at 5 micromoles per square meter per second and a control treatment of 1
236 der continuous irradiation at 400 micromoles per square meter per second and under 12 hours irradianc
237 photosynthetic photon flux of 200 micromoles per square meter per second cool-white fluorescent (CWF)
239 per second CWF; (c) 12 hours 400 micromoles per square meter per second CWF plus 12 hours dim CWF at
240 er per second; (d) 12 hours [400] micromoles per square meter per second CWF plus 12 hours dim incand
241 rescent (CWF); (b) continuous 400 micromoles per square meter per second CWF; (c) 12 hours 400 microm
242 tinuous irradiation at 560 to 580 micromoles per square meter per second from either metalhalide (MH)
243 der continuous irradiation of 400 micromoles per square meter per second of photosynthetic photon flu
244 tinuous irradiation at 200 or 400 micromoles per square meter per second resulted in severe stunting
245 utants can survive under 2000 microeinsteins per square meter per second with air, although they have
246 levels of PPF (100, 200, and 400 micromoles per square meter per second) and two lamp types, metal h
247 osynthetic photon flux (PPF), 200 micromoles per square meter per second, but with phytochrome photoe
249 nd CWF plus 12 hours dim CWF at 5 micromoles per square meter per second; (d) 12 hours [400] micromol
250 etic photon fluxes (PPF, 400-2080 micromoles per square meter per second; 22-150 moles per square met
251 0 to an average of 86 kilograms of wet mass per square meter per year when the grazing assemblage is
252 Net GWP (grams of carbon dioxide equivalents per square meter per year) ranged from 110 in our conven
253 dard-blood-pressure group (-1.17 vs. -0.57 g per square meter per year, P<0.001); urinary albumin exc
254 hk0 edges are in the range of 10(-10) moles per square meters per second, two orders of magnitude fa
255 adjuvant treatment with doxorubicin (<60 mg per square meter) plus cyclophosphamide in node-positive
256 axel, administered weekly at a dose of 80 mg per square meter, plus carboplatin (AUC, 6) for six cycl
257 changes over this period of about -0.1 watt per square meter, reducing the recent global warming tha
258 louds over the TP, with a 1.98 +/- 0.39-watt per square meter reduction in surface net CRE correspond
259 bal aerosol radiative forcing of +0.14 watts per square meter relative to business-as-usual scenario.
265 t the model underestimates by 25 to 30 watts per square meter the amount of solar energy absorbed by
267 between 1.1x10(11) and 4.4x10(11) platelets per square meter, the number of platelets in the prophyl
268 pole moment of 12.5 +/- 1.4 x 10(22) amperes per square meter, three times greater than mean Cenozoic
269 LSTs (dose range, 0.5 x 107 to 2 x 107 cells per square meter) to 11 patients with ALL (8 pediatric,
270 lating doses of mLSTs (0.5 to 10 x 107 cells per square meter) to 25 trial enrollees, 17 with high ri
271 adhesion energies (E(ad) >/=-15 millijoules per square meter) to mica in saline pH 3.5 to 7.5 and re
272 re meter on day 1) plus capecitabine (825 mg per square meter twice a day on days 1 to 14), or doceta
273 n days 1 and 29, and 2 g of oral hydroxyurea per square meter twice weekly for six weeks (group 2); o
274 weeks (group 2); or 3 g of oral hydroxyurea per square meter twice weekly for six weeks (group 3).
275 , isotropic fatigue threshold of 2320 joules per square meter, ultracompressibility (8% strain after
278 e meter (cooling), compared with +2.45 watts per square meter (warming) due to anthropogenic greenhou
280 a low Faraday rotation (12.0 +/- 0.7 radians per square meter), we infer negligible magnetization in
281 ter of body-surface area, followed by 250 mg per square meter weekly for the duration of radiotherapy
282 4 weeks or gemcitabine monotherapy (1000 mg per square meter) weekly for 7 of 8 weeks (cycle 1) and
283 uare meter) or intravenous cisplatin (100 mg per square meter) were administered at three-week interv
284 cta column to be ~10(-6) to 10(-5) kilograms per square meter, which is consistent with LCROSS estima
285 mer from BC in Arctic snow was about 3 watts per square meter, which is eight times the typical prein
286 ts generate approximately 1 megawatt of heat per square meter, which maintains the catalyst surface a
287 to a radiative forcing of -0.5 +/- 0.4 watts per square meter, which suggests that reaching lower car
288 arth to space increased by more than 5 watts per square meter, while reflected sunlight decreased by
290 with mitral-valve repair and 60.6+/-39.0 ml per square meter with mitral-valve replacement (mean cha